Executive Director, Haematology, International Commercial Launch Strategy

Shape the international launch strategy for a leading CML treatment, ensuring alignment with haematology priorities and patient needs. Coordinate cross-functional collaboration across medical, regulatory, access, commercial, and supply teams to support effective execution. Enable launch readiness across priority markets by identifying risks early and supporting practical mitigation plans. Use market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging. Partner with regional and country teams to support local execution while maintaining alignment with global strategy. Define, monitor, and govern critical launch milestones and performance indicators to support timely, evidence-based decisions. Communicate clearly with senior leaders on vision, progress, and strategic priorities across international markets. Promote strong standards of compliance, operational excellence, and best practice in launch execution. Contribute to development planning by helping shape target product profiles and evidence needs that support market access potential. Lead commercial excellence initiatives and strengthen customer-centred engagement approaches across regions.

Welcome to where we thrive together! Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need as soon as possible. This is an opportunity to influence the journey from development to commercialisation while enabling teams across regions to make a meaningful difference for people living with serious blood cancers.

• Recent, significant Profit and Loss (P&L;) leadership experience at country level.

• Approximately 15 years of progressive commercial experience across country and above‑country roles.

• Proven success leading launches and shaping therapeutic area strategy across diverse international markets.

• Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans.

• Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets.

• Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases.

• Consistent record of influencing cross‑unit and cross‑functional teams to achieve shared strategic goals.

• Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence‑based decision‑making.